VivoSeq
Other

Drug Monitoring

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Drug Monitoring is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

11/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

19

clinical trials

Completed8 · 42%
Unknown status8 · 42%
Terminated1 · 5%
Withdrawn1 · 5%
Recruiting1 · 5%

Trial Activity

19 trials

Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen
Unknown status··N/A·NCT03582865·100 enrolled
Therapeutic Drug Monitoring of Anxiolytics in Children
Unknown status··Phase 4·NCT03960671·500 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)